Financials in USD. Standardized financial statements.
A compact view of how Amarantus BioScience Holdings, Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $95,331 | $0 | $74,700 | $20.00M | $0 | $0 | $0 | $0 | $0 | $0 |
| Revenue Growth? | 0.0% | -100.0% | -99.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $0 | $0 | $0 | $0 | $0 | $17,240 | $58,925 | $176,000 | $0 | $70,049 |
| Gross Profit? | $95,331 | $0 | $74,700 | $20.00M | $0 | -$17,240 | -$58,925 | -$176,000 | $0 | $0 |
| Gross Margin? | +100.0% | 0.0% | +100.0% | +100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $363,359 | $147,923 | $702,477 | $1.67M | $3.04M | $3.20M | $8.56M | $24.82M | $21.35M | $5.64M |
| Operating Income? | -$268,000 | -$148,000 | -$628,000 | $18.33M | -$3.04M | -$3.21M | -$8.62M | -$24.82M | -$21.35M | -$5.71M |
| EBITDA? | -$4.53M | -$9.96M | -$421,703 | $18.55M | -$3.04M | -$3.15M | -$7.47M | -$24.64M | -$21.35M | -$5.64M |
| Income Before Tax | -$4.76M | -$10.20M | -$628,000 | $18.38M | -$10.58M | -$4.44M | -$11.58M | -$25.21M | -$27.28M | -$15.13M |
| Income Tax Expense | $0 | $0 | $0 | $0 | -$3,039 | $0 | $5 | $0 | $0 | $0 |
| Net Income? | -$4.76M | -$10.20M | -$628,000 | $18.38M | -$10.58M | -$4.44M | -$11.58M | -$25.21M | -$27.28M | -$15.13M |
| EPS? | $-0.01 | $-0.02 | $-0.00 | $0.07 | $-0.05 | $-0.07 | $-0.15 | $-4.17 | $-5.71 | $-5.03 |
| Diluted EPS? | $-0.01 | $-0.02 | $-0.00 | $0.07 | $-0.05 | $-0.07 | $-0.15 | $-4.17 | $-5.71 | $-5.03 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality